Posted on

In brief: Indonesia’s Burgreens raises funding; Shippit enters Singapore

Burgreens investment

The story: DealStreetAsia reports that Indonesian plants-based food chain Burgreens has raised an undisclosed sum in funding.

Investors: Teja Ventures, Angel Investment Network of Indonesia.

What is Burgreens?: It is a plant-based food company which operates restaurants as well as provides Asian taste plant-based meats alternative. Burgreens was started in November 2013 by a young vegetarian couple Max and Helga.

Started as Jakarta’s first organic healthy plant-based eatery and catering, Burgreens has now grown into a community-based social business connecting local farmers, a passionate team, and conscious customers to bring great tasting plant-based meals for everyone.

Shippit enters Singapore

The story: Australian SaaS logistics startup Shippit has officially launched in Singapore. The company has partnered with Shopify to launch a cash on delivery model for Southeast Asian merchants and retailers.

Plans: It aims to expand into Malaysia, the Philippines, and Indonesia in the near future.

What is Shippit?: The Shippit platform enables retailers to instantly ship with Asia’s leading carriers, share tracking and notifications and access dedicated delivery support. Shippit serves more than 6,000 customers a month across Australia, New Zealand, and Southeast Asia. The company is backed by Aura Group.

SEA startups in MedTech programme

The story: US-based nonprofit accelerator MedTech Innovator, in partnership with Asia Pacific Medical Technology Association (APACMed), has announced the 20 companies selected to participate in its Asia Pacific Accelerator programme.

List of Southeast Asian startups:

  • CellWave Technologies (Singapore)
  • Credo Diagnostics Biomedical (Singapore)
  • FathomX (Singapore)
  • Magloy Tech (Singapore)
  • Naluri Life (Malaysia)
  • Recornea (Singapore)
  • Sporogenics (Singapore)
  • X-ZELL (Singapore)

More details: Over 170 companies applied for the programme, but only four startups from the 2020 Asia Pacific cohort will advance to compete in the Grand Finals. The winning company, which will be determined by audience vote, stands to win a non-dilutive cash prize and the title of 2020 MedTech Innovator Asia Pacific Winner. In total, up to US$300,000 in cash prizes and awards will be given out to Accelerator companies.

Plum’s seed funding

The story: Plum, a Bengaluru-based group health insurance startup, providing modern health benefits to corporates, has raised INR 7 crore (over US$900,000) in seed funding.

Investors: Incubate Fund (lead), Gemba Capital, Tracxn Labs, angel investors

Plans with the capital: To scale business and engineering teams so as to solve some of the hardest engineering challenges in insurtech and build innovative distribution channels.

What is Plum?: Plum claims to provide employers and employees with more flexibility, transparent pricing, and quality healthcare experience. The platform says it understands the needs of a corporate and guides them on setting up their group health insurance in a short time.

It is working with nine insurance companies and has got 100-plus companies as customers.

The post In brief: Indonesia’s Burgreens raises funding; Shippit enters Singapore appeared first on e27.